IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001
Globe Newswire•26/08/2026•08:30 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.